MRNA Low Risk Short Position
Atualizado
MRNA is hillariously overbought, with stochastics, EMA's, bollingerbands, MACD, and RSI on the daily chart all showing prime conditions for a short position.
Here's the chart showing those indicators:
I am going to be watching this on Monday and throughout the week, looking for a short position entrance. I played it on Tuesday for a nice $50/ share short with similar technical indicators. Hoping to duplicate that again this week. Might go debit, might go credit, not entirely sure how I'll play this yet. IVR is somewhat high for a credit trade, and since they have earnings coming up, I imagine that will continue to increase. For that reason, a debit trade might be the winner here. That said, if IVR collapses, that will hurt my trade.
Still formulating the exact plan, but I am going to play MRNA short in some capacity.
I am anticipating a retracement to the $300.00 / level in the short term at $250.00 in the next few months.
Here's the chart showing those indicators:
I am going to be watching this on Monday and throughout the week, looking for a short position entrance. I played it on Tuesday for a nice $50/ share short with similar technical indicators. Hoping to duplicate that again this week. Might go debit, might go credit, not entirely sure how I'll play this yet. IVR is somewhat high for a credit trade, and since they have earnings coming up, I imagine that will continue to increase. For that reason, a debit trade might be the winner here. That said, if IVR collapses, that will hurt my trade.
Still formulating the exact plan, but I am going to play MRNA short in some capacity.
I am anticipating a retracement to the $300.00 / level in the short term at $250.00 in the next few months.
Nota
Looking for an entrance around the $350.00 range, but am going to wait for price action on Monday to determine an exact entry. I feel like it might push upwards further, possibly $375.00, but I think a steep selloff is due, and I believe it will happen this week.
Aviso legal
As informações e publicações não devem ser e não constituem conselhos ou recomendações financeiras, de investimento, de negociação ou de qualquer outro tipo, fornecidas ou endossadas pela TradingView. Leia mais em Termos de uso.